bone marrow transplantation, cellular therapy, oncology, hematology
Return to Article Details ARE WE READY TO INDICATE MYELODYSPLASTIC SYNDROME PATIENTS TO HEMATOPOIETIC STEM CELL TRANSPLANTATION BASED ON THEIR GENETIC STATUS? Download Download PDF